Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

2. Liquidity and Financial Condition (Details Narrative) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Liquidity And Financial Condition
Net loss	$ (8,203,000)us-gaap_NetIncomeLoss	$ 3,735,000us-gaap_NetIncomeLoss
Accumulated deficit	(142,213,000)	(134,010,000)
Working capital	$ 7,066,000ocls_WorkingCapital	$ 1,970,000ocls_WorkingCapital

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.